MCK

#2140
McKesson Corporation Common Stock
7.4 3 USD
-1.86%
セクター: ヘルスケア
ベース: USD
利益通貨: USD
日中レンジ
7.41
748.47
1年のレンジ
7.41
999.00
1日の変化
-1.86%
月次変化
-99.10%
6か月変化
-99.15%
1年の変化
-99.07%
以前の終値
7.5 7
Open
746.1 4
安値
7.4 1
High
748.4 7
ボリューム
1 590
チャート全体を表示 Full chart

Financials

概要 明細書 統計 配当金
期次 年次
  • Market Capitalization 893.07 M
  • Employee 43 K
  • Founded N/A
  • CEO Brian S. Tyler
  • Website www.mckesson.com
  • Headquarter Delaware, United States
  • FIGI BBG000DYGNW7
  • Industry 医療流通
総売上高
当期純利益
1株当たり基本利益（基本EPS）
有利子負債合計
フリーキャッシュフロー
現金および現金同等物
株価収益率
22.55
売上高対価格比率
0.27
1株当たり配当金
3.17
配当利回り（％）
0.37

McKesson Corporation Common Stock

McKesson Corporation is an American publicly traded company that distributes pharmaceuticals and provides health information technology, medical supplies, and health management tools. The company delivers a third of all pharmaceutical products used or consumed in North America and employs over 80,000 employees. With $308.9 billion in 2024 revenue, it is the ninth-largest company by revenue in the United States and the nation's largest health care company. The company is headquartered in Irving, Texas. It is a component of the S&P 500 and is listed on the New York Stock Exchange, where it is traded under the ticker symbol "MCK". McKesson provides extensive network of infrastructure for the healthcare industry and was an early adopter of technologies, including barcode scanning for distribution, pharmacy robotics, and RFID tags. The company has been named in a federal lawsuit for profiting from the opioid epidemic in the United States. Throughout the COVID-19 pandemic, McKesson was a key vaccine distributor, serving as the US government's centralized distributor for hundreds of millions of COVID-19 vaccine doses and ancillary supply kits for over a billion doses.

ニュース